First treatment for lipodystrophy approved in Europe
admin 1st August 2018 Uncategorised 0Aegerion Pharmaceuticals Myalepta approved by EC More: First treatment for lipodystrophy approved in Europe Source: News
read moreAegerion Pharmaceuticals Myalepta approved by EC More: First treatment for lipodystrophy approved in Europe Source: News
read moreDrug becomes the first oral therapy and Janus kinase (JAK) inhibitor available for UC More: Pfizer's Xeljanz cleared for ulcerative colitis in Europe Source: News
read morePrescription drug sales were $7.1 billion for the first half of the year More: Boehringer sales rise as Jardiance and Ofev thrive Source: News
read moreEliquis, Ibrance, Xeljanz and biosimilars help drive profit growth More: Biosimilars and key brands drive Pfizer to raise forecasts Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals